IP Library Granted Patent US 9,333,250
Granted Patent B2
US 9,333,250 · App. 12/226,088 · Granted May 10, 2016

Methods and compositions for treating bacterial infection

Inventor: Kwang S. Kim (Reistertown, MD)
Assignee: The Johns Hopkins University
A61K39/0258C07K14/245G01N33/5308A61K2039/505A61K2039/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,250
App. No.
12/226,088
Granted
May 10, 2016
Kind
B2
Abstract

The present invention relates to methods and compositions for the treatment of bacterial infection, for example extraintestinal E. coli infection such as E. coli bacteremia, meningitis and sepsis. The invention relates also to methods of diagnosis and prevention.

Claims (9)

1. A method for immunizing a subject against a bacterial infection, the method comprising administering to the subject one or more isolated polypeptides or an isolated mRNA or synthetic nucleic acid encoding the one or more polypeptides,

wherein the one or more polypeptides are encoded by one or more Escherichia coli ( E. coli )-derived island (RDI) sequences selected from the group consisting of RDI 1, RDI 4, RDI 7, RDI 12, RDI 13, RDI 16, RDI 20, RDI 21 and RDI 22,

thereby immunizing the subject against the bacterial infection.

2. The method of claim 1 , wherein the bacterial infection is an E. coli infection.

3. The method of claim 2 , wherein the E. coli infection is an extraintestinal E. coli infection.

4. The method of claim 3 , wherein the extraintestinal E. coli infection is selected from the group consisting of: bacteremia, sepsis, meningitis, urinary tract infection and pneumonia.

5. The method of claim 1 , wherein the method stabilizes, reduces the symptoms of, or ameliorates a disease or disorder characterized by the bacterial infection.

6. The method of claim 1 , wherein the RDI sequence is derived from an E. coli strain selected from the group consisting of RS 218, C5, IHE3034, RS167, A90, S88 and S95.

7. A method of modulating an immune response in a subject in need thereof, the method comprising administering to the subject the one or more isolated polypeptides or the isolated mRNA or synthetic nucleic acid encoding the one or more polypeptides of claim 1 , thereby modulating the immune response in the subject.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 31, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044329/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2008
From: KIM, KWANG S.
To: JOHNS HOPKINS UNIVERSITY, THE
Reel/Frame 021835/0182 →
Continuity (2)
Provisional Application 60789791 · Apr 6, 2006
Related Publication 20100136027A1 · Jun 3, 2010